Dysplastic gangliocytoma of the cerebellum with an unusual radiological finding
Authors:
Markéta Hojsáková 1; Jana Engelová 2,3; Radim Brabec 4; Tereza Piskáčková 1; Marián Švajdler jr. 5,6; Tomáš Klinger 7; Iva Dolinová 1; Renata Michalovská 8; Tomáš Jirásek 7
Authors‘ workplace:
Oddělení genetiky a molekulární diagnostiky, Centrum PATOS, Krajská nemocnice Liberec, a. s.
1; Radiodiagnostické oddělení, Nemocnice Jablonec nad Nisou, p. o.
2; Proton Therapy Center Czech s. r. o., Praha
3; Oddělení neurochirurgie, Neurocentrum, Krajská nemocnice Liberec, a. s.
4; Šiklův ústav patologie, Univerzita Karlova, Lékařská fakulta Plzeň, Fakultní nemocnice v Plzni
5; Bioptická laboratoř, s. r. o., Plzeň
6; Oddělení patologie, Centrum PATOS, Krajská nemocnice Liberec, a. s.
7; GHC GENETICS, s. r. o, Praha
8
Published in:
Čes.-slov. Patol., 61, 2025, No. 2, p. 92-97
Category:
Original Article
Overview
Dysplastic gangliocytoma of the cerebellum, also known as Lhermitte-Duclos disease (LDD), is a rare lesion of the posterior cranial fossa, classified among glioneuronal and neuronal tumors of the CNS, WHO grade 1. It typically has a characteristic radiological appearance on magnetic resonance imaging in the form of „tiger stripes“ on T2-weighted images. In adults, LDD is often associated with Cowden syndrome and PTEN gene mutations. Our case report presents a 51-year-old patient with a somewhat atypical finding on magnetic resonance imaging, where histopathological examination surprisingly revealed dysplastic gangliocytoma of the cerebellum with a PTEN gene mutation, subsequently confirmed to be of germline origin. The patient was then examined for other manifestations of Cowden syndrome and is being followed up in a specialized clinic, with cascade genetic testing also conducted in her family.
Keywords:
dysplastic gangliocytoma of the cerebellum – Lhermitte-Duclos disease – Cowden syndrome – PTEN gene
Sources
- Han C, Zhang Y, Ran C, Luo Y, Li W. Diverse imaging findings of Lhermitte-Duclos disease. Clin Radiol 2023; 78(1): 33-39.
- Vybíhal V, Fadrus P, Musil J, Vidlák M. Morbus Lhermitte-Duclos – kazuistika. Česká a slovenská neurologie a neurochirurgie 2008; 71 (Suppl. 2): 64-64.
- Joo G, Doumanian J. Radiographic Findings of Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease) in a Woman with Cowden Syndrome: A Case Study and Literature Review. J Radiol Case Rep 2020; 14(3): 1-6.
- Alanazi AI, Alanezi T, Aljofan ZF, Alarabi A, Elwatidy S. Lhermitte-Duclos disease: A systematic review. Surg Neurol Int 2023; 14: 351.
- Miguelote S, Silva R, Fougo JL, Barbosa LE, Araújo Teixeira JP. Cowden syndrome is a risk factor for multiple neoplasm: a case report. World J Surg Oncol 2020; 18(1): 211.
- Aggari HE, Nasri S, Zohra AF, Aichouni N, Kamaoui I, Skiker I. Association between Cowden syndrome and Lhermitte-Duclos disease: A case report of an uncommon Genetic Hamartomatous Disorder. Radiol Case Rep 2023; 18(8): 2763-2767.
- Kleinschmidt-deMasters BK, Pekmeczi M, Rodríguez F, Tihan T. Diagnostic Pathology: Neuropathology (3rd edn). Philadelphia: Elsevier; 2022: 196-199.
- Válková M, Kašparová P, Adamkov J, Krůpa P. Jaká je vaše diagnóza? Odpověď: Dysplastický cerebelární gangliocytom (onemocnění Lhermitte-Duclos). Cesk Patol 2018; 4: 201.
- Jiang T, Wang J, Du J et al. Lhermitte-Duclos Disease (Dysplastic Gangliocytoma of the Cerebellum) and Cowden Syndrome: Clinical Experience From a Single Institution with Long-Term Follow-Up. World Neurosurg 2017; 104: 398-406.
- Monjarás-Romo G, Zavala-Romero L, Tejada-Pineda MF et al. Lhermitte-Duclos Disease: A Case Series. Cureus 2023; 15(8): 44326.
- Balasundaram P, Mallikarjuna VS, Suresh Bapu KR. Dysplastic cerebellar gangliocytoma (Lhermite-Duclos disease): a rare entity and review of literature. Int Clin Pathol J 2018; 6(2): 84–85.
- Kılboz BB, Tıraş R. Lhermitte-Duclos disease presenting as cognitive impairment: A case report with a seven-year follow-up. Turk J Neurol 2024; 30(4): 276-278.
- Douglas-Akinwande AC, Payner TD, Hattab EM. Medulloblastoma mimicking Lhermitte- -Duclos disease on MRI and CT. Clin Neurol Neurosurg 2009; 111(6): 536-539.
- Yehia L, Eng C. PTEN Hamartoma Tumor Syndrome. 2001 Nov 29 [Updated 2021 Feb 11]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2025.
- Kapačinskaitė M, Stratica N, Adomaitienė I, Rascon J, Vaišnytė B. A systematic review of Bannayan-Riley-Ruvalcaba syndrome. Sci Rep 2024; 14(1): 211-219.
- Nelen MR, Kremer H, Konings IB et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 1999; 7(3): 267-273.
- Foretová L, Macháčková E, Gaillyová R. Hereditární nádorová onemocnění v klinické praxi. In: Puchmajerová A. Hamartogenní polypózní syndromy. Praha: Grada Publishing; 2022: 267-275.
- Podralska M, Nowakowska D, Steffen J, Cichy W, Slomski R, Plawski A. First Polish Cowden syndrome patient with confirmed PTEN gene mutation. Arch Med Sci 2010; 6(1): 135-137.
- Goh CP, Wu B, Feng TT, Chou N. Cowden syndrome and Lhermitte-Duclos disease: A case report and review of the literature. J Clin Images Med Case Rep 2021; 2(4): 1250.
- Zhou XP, Waite KA, Pilarski R, el al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003; 73(2): 404-411.
- Takayama T, Muguruma N, Igarashi M et al. Clinical Guidelines for Diagnosis and Management of Cowden Syndrome/PTEN Hamartoma Tumor Syndrome in Children and Adults-Secondary Publication. J Anus Rectum Colon 2023; 7(4): 284-300.
- Tibarewal P, Rathbone V, Constantinou G et al. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development. J Pathol 2022; 258(4): 382-394.
- Garofola C, Jamal Z, Gross GP. Cowden Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
- Ngeow J, Stanuch K, Mester JL, Barnholtz-Sloan J, Eng C. Second malignant neoplasms in Cowden syndrome patients with underlying germline PTEN mutations. J Clin Oncol 2014; 32: 1818-1824.
- Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic cri- teria. J Natl Cancer Inst 2013; 105(21): 1607-1616.
- Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007; 44(9): 579-585.
- Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan- -Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011; 48(8): 505-512.
- Awwad EE, Levy E, Martin DS, Merenda GO. Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement. AJNR Am J Neuroradiol 1995; 16(8): 1719-1720.
Labels
Anatomical pathology Forensic medical examiner ToxicologyArticle was published in
Czecho-Slovak Pathology
2025 Issue 2
Most read in this issue
- Umělá inteligence v patologii – pokračování
- První rozhovor s novým šéfredaktorem našeho časopisu
- Machine learning in digital pathology
- Utilization of Artificial Intelligence Algorithms for the Diagnosis of Breast, Lung, and Prostate Cancer